3H-1,2,4-Triazol-3-one, 2-(1-ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-

3H-1,2,4-Triazol-3-one, 2-(1-ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- Struktur
212632-01-4
CAS-Nr.
212632-01-4
Englisch Name:
3H-1,2,4-Triazol-3-one, 2-(1-ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-
Synonyma:
Vigabatrin Impurity 9;Posaconazole Impurity 155;4-(4-(4-(4-Hydroxyphenyl)piperazin-1-yl)phenyl)-1-(pentan-3-yl)-1H-1,2,4-triazol-5(4H)-one;2-(1-Ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one;3H-1,2,4-Triazol-3-one, 2-(1-ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-;3H-1,2,4-TRIAZOL-3-ONE, 2-(1-ETHYLPROPYL)-2,4-DIHYDRO-4-[4-[4-(4-HYDROXYPHENYL)-1-PIPERAZINYL]PHENYL]-(WXG01575)
CBNumber:
CB12716030
Summenformel:
C23H29N5O2
Molgewicht:
407.51
MOL-Datei:
212632-01-4.mol

3H-1,2,4-Triazol-3-one, 2-(1-ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- Eigenschaften

Siedepunkt:
596.4±60.0 °C(Predicted)
Dichte
1.23±0.1 g/cm3(Predicted)
pka
12.18±0.30(Predicted)

Sicherheit

3H-1,2,4-Triazol-3-one, 2-(1-ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

2-(1-Ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one is an intermediate in the synthesis of Deshydroxy Posaconazole Impurity (A6480252), which is a 2,2,5-tetrahydrofuran regioisomers of SCH 51048 (A648025) that exhibit antifungal activity.

3H-1,2,4-Triazol-3-one, 2-(1-ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3H-1,2,4-Triazol-3-one, 2-(1-ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Wuxi AppTec 022-59987777 13552403979
jia_guoqiang@wuxiapptec.com China 22346 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
malulu@leyan.com China 55023 58
Shandong Wadesen Biotechnology Co. LTD 0531-88723173 18596073690
1047208234@qq.com China 3731 58
Changzhou Bojia Biomedical Technology Co., Ltd. 2122619822
czbjpharma@126.com China 18488 58
Suzhou Meishi Biotechnology Co., Ltd. 1173954148q
meishipharma@126.com China 20035 58
Suzhou Haohai Pharmaceutical Technology Co., Ltd. 13810165869
xiaodongbai@haotianpharm.com China 195 58
Suzhou Haiben Pharmaceutical Co., Ltd 14760821013 14760821013
1816280386@qq.com China 8068 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016
3287908757@qq.com China 9887 58

  • 3H-1,2,4-Triazol-3-one, 2-(1-ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-
  • 3H-1,2,4-TRIAZOL-3-ONE, 2-(1-ETHYLPROPYL)-2,4-DIHYDRO-4-[4-[4-(4-HYDROXYPHENYL)-1-PIPERAZINYL]PHENYL]-(WXG01575)
  • 2-(1-Ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one
  • Posaconazole Impurity 155
  • Vigabatrin Impurity 9
  • 4-(4-(4-(4-Hydroxyphenyl)piperazin-1-yl)phenyl)-1-(pentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
  • 212632-01-4
Copyright 2019 © ChemicalBook. All rights reserved